InsidersTradesSigma
Follow the 바이오플러스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오플러스 has logged 1 insider filings. Market capitalisation: €202.2bn. The latest transaction was reported on 2 April 2026 (Purchase). Among the most active insiders: 정현규. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
BioPlus is a healthcare and pharmaceutical company listed on the XKRX. It specializes in the development of biopharmaceutical products.